Feasibility of a home-based computerized cognitive training for pediatric patients with congenital or acquired brain

Claudia Corti1, Geraldina Poggi1, Romina Romaniello2

  • 1Neuro-oncological and Neuropsychological Rehabilitation Unit, Scientific Institute IRCCS Eugenio Medea, Bosisio Parini, Lecco, Italy.

Plos One
|June 21, 2018
PubMed

Insights

Home-based computerized cognitive training (CCT) is feasible for Italian adolescents with brain damage. This remote telerehabilitation approach using a foreign language program demonstrated high adherence and completion rates.

Area of Science:

  • Neuroscience
  • Rehabilitation Medicine
  • Digital Health

Background:

  • Pediatric brain damage often leads to cognitive deficits.
  • Cognitive rehabilitation is crucial for managing these impairments.
  • Home-based computerized cognitive training (CCT) offers accessible telerehabilitation.

Purpose of the Study:

  • To assess the feasibility of home-based CCT for Italian adolescents with brain damage.
  • To evaluate the use of a commercially available, English-language CCT program in a non-English speaking context.
  • To explore the potential of foreign-language CCT programs in resource-limited telerehabilitation settings.

Main Methods:

  • 32 adolescents (11-16 years) with brain damage participated.
  • A total of 40 CCT sessions were completed over 8 weeks.
  • Feasibility was assessed using 9 established criteria, with face-to-face instruction provided.

Main Results:

  • All 9 feasibility criteria were successfully met.
  • High adherence was observed, with 31 of 32 participants completing the program.
  • 94.2% of training sessions were completed on time, with no significant technical issues.

Conclusions:

  • Home-based CCT is a feasible telerehabilitation strategy for adolescents with brain damage.
  • Foreign-language CCT programs can effectively address the lack of native-language options.
  • This approach expands treatment opportunities in areas with limited telerehabilitation investment.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
266
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
320
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
239
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
305
Cognitive Dissonance01:38

Cognitive Dissonance

Social psychologists have documented that feeling good about ourselves and maintaining positive self-esteem is a powerful motivator of human behavior (Tavris & Aronson, 2008). In the United States, members of the predominant culture typically think very highly of themselves and view themselves as good people who are above average on many desirable traits (Ehrlinger, Gilovich, & Ross, 2005). Often, our behavior, attitudes, and beliefs are affected when we experience a threat to our...
37.5K
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
161